다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Sage Therapeutics Inc (SAGE)
Sage Therapeutics Inc (SAGE) 뉴스

SAGE

Sage Therapeutics (SAGE)

Sage Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SAGE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/07	19:30	Business Wire	Sage Therapeutics to Participate in Upcoming May Investor Conferences	NASDAQ:SAGE	Sage Therapeutics Inc
2024/04/25	19:30	Business Wire	Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress	NASDAQ:SAGE	Sage Therapeutics Inc
2024/04/17	19:30	Business Wire	Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease	NASDAQ:SAGE	Sage Therapeutics Inc
2024/04/11	19:30	Business Wire	Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/28	20:30	Business Wire	Sage Therapeutics to Present at Upcoming March Investor Conferences	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/22	06:35	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/16	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/16	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/15	06:09	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/14	21:49	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/14	21:20	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/14	20:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/14	20:30	Business Wire	Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/01	07:25	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:SAGE	Sage Therapeutics Inc
2024/02/01	06:50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/31	20:30	Business Wire	Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/25	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/23	22:13	Edgar (US Regulatory)	Form SC TO-I - Tender offer statement by Issuer	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/08	20:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/08	20:32	Business Wire	Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/08	20:30	Business Wire	Sage Therapeutics Announces Changes to Board of Directors	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/05	06:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SAGE	Sage Therapeutics Inc
2024/01/02	20:30	Business Wire	Sage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024	NASDAQ:SAGE	Sage Therapeutics Inc
2023/12/19	22:32	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SAGE	Sage Therapeutics Inc
2023/12/19	22:30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SAGE	Sage Therapeutics Inc
2023/12/14	20:30	GlobeNewswire Inc.	ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S.	NASDAQ:SAGE	Sage Therapeutics Inc
2023/12/14	20:30	Business Wire	ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S.	NASDAQ:SAGE	Sage Therapeutics Inc
2023/12/08	23:00	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:SAGE	Sage Therapeutics Inc
2023/12/08	22:30	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SAGE	Sage Therapeutics Inc
2023/11/08	20:30	Business Wire	Sage Therapeutics to Present at Upcoming November Investor Conferences	NASDAQ:SAGE	Sage Therapeutics Inc

검색 관련기사 보기:NASDAQ:SAGE

1 2 3 4 5 6 7 8 9 10 다음 >>

Ish Jap Esg U-d

Ubs Msci Usa Select Fact...

Sierra Lake Acqusition

Liberty Resources Acquis...

Jpm Em Rei Dist

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관